Active Ingredient(s): Thalidomide
FDA Approved: * July 16, 1998
Pharm Company: * CELGENE
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Thalomid Overview

Thalidomide, sold under the brand names Contergan and Thalomid among others, is a medication used to treat a number of cancers (including multiple myeloma), graft-versus-host disease, and a number of skin conditions including complications of leprosy.[3] While it has been used in a number of HIV-associated conditions, such use is associated with increased levels of the virus.[3] It is administered orally.[3] Common side effects include sleepines...

Read more Thalomid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Thalomid Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 100mg, 150mg, 200mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Thalomid: (4 results)

Sorted by National Drug Code
  • 59572-205 Thalomid 50 mg Oral Capsule by Celgene Corporation
  • 59572-210 Thalomid 100 mg Oral Capsule by Celgene Corporation
  • 59572-215 Thalomid 150 mg Oral Capsule by Celgene Corporation
  • 59572-220 Thalomid 200 mg Oral Capsule by Celgene Corporation

Other drugs which contain Thalidomide or a similar ingredient: (1 result)